Who invested in EvodiaBio

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2024, from 2 sources

$7.2MSeries A$7.1MVenture

Latest round: Venture, $7.1MDec 2025
Biggest round: $7.2MSeries A · Jun 2024
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2025

$7.2MSeries A$7.1MVenture

First round: Series A, $7.2M
Biggest round: $7.2M
Between rounds: 18 months

The rounds

Dec 2025
Venture$7.1M2 new1 returning
Source recorded
Jun 2024
Series A$7.2M1 new
- Export and Investment Fund
Source recorded

Founders and team

From EvodiaBio's own website: 4 founders, 16 on the team.

Sotirios KampranisChief of R&D and Co-founder

Victor FormanCTO & Co-founder

Jarne ElleholmChairman & Co-founder

Simon DusséauxCSO & Co-founder

Camilla Kloss FennebergCEO
Julie KamperSales & Marketing Coordinator
Søren Kjær HenningsenCFO
Nicolás DrocchiHead of Production
Andreas FibigBoard Member
Anne CabotinBoard Member
Bede IrelandSales Manager
Chad McRaeNorth America Sales Manager
Flemming BesenbacherBoard Member
Johan Bitsch NielsenBoard Member
Kyle TeameyBoard Member
Matt JohnsonNorth America Sales Manager
Oskar OlofssonResearch Scientist
Sebastián Tamayo RojasResearch Scientist
Stuart WalshQA/QC Manager
Teresa CaniveDigital Marketing Manager

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2024Venture2025Export and Investment Fund

RA Capital ManagementBioInnovation Institute

Everyone who backed them

Export and Investment FundVC firm2rounds

RA Capital ManagementPrivate equity1round

BioInnovation InstituteVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists EvodiaBio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.